HIGHLIGHTS
- who: August and colleagues from the Hospital, China National University of Malaysia, Malaysia have published the research: Oroxylin A ameliorates AKI-to-CKD transition through maintaining PPAR u03b1 -BNIP3 signaling-mediated mitochondrial homeostasis, in the Journal: (JOURNAL)
- what: In the present study, based on the effect of OA in alleviating acute liver injury and acute lung injury (Tseng et_al, 2012; Huang et_al, 2015), the therapeutic potential of OA in AKI was evaluated and its molecular mechanism was explored. This study has identified the ability of OA in ameliorating AKI and delaying its transition to CKD . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.